Literature DB >> 33396584

Markers Associated with COVID-19 Susceptibility, Resistance, and Severity.

Aisha D Fakhroo1, Asmaa A Al Thani2, Hadi M Yassine2.   

Abstract

In December 2019, the latest member of the coronavirus family, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in Wuhan, China, leading to the outbreak of an unusual viral pneumonia known as coronavirus disease 2019 (COVID-19). COVID-19 was then declared as a pandemic in March 2020 by the World Health Organization (WHO). The initial mortality rate of COVID-19 declared by WHO was 2%; however, this rate has increased to 3.4% as of 3 March 2020. People of all ages can be infected with SARS-CoV-2, but those aged 60 or above and those with underlying medical conditions are more prone to develop severe symptoms that may lead to death. Patients with severe infection usually experience a hyper pro-inflammatory immune reaction (i.e., cytokine storm) causing acute respiratory distress syndrome (ARDS), which has been shown to be the leading cause of death in COVID-19 patients. However, the factors associated with COVID-19 susceptibility, resistance and severity remain poorly understood. In this review, we thoroughly explore the correlation between various host, viral and environmental markers, and SARS-CoV-2 in terms of susceptibility and severity.

Entities:  

Keywords:  COVID-19; SARS; pathogenesis; resistance; susceptibility

Year:  2020        PMID: 33396584     DOI: 10.3390/v13010045

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  12 in total

Review 1.  Laboratory Biomarkers for Diagnosis and Prognosis in COVID-19.

Authors:  Denise Battaglini; Miquéias Lopes-Pacheco; Hugo C Castro-Faria-Neto; Paolo Pelosi; Patricia R M Rocco
Journal:  Front Immunol       Date:  2022-04-27       Impact factor: 8.786

2.  Intragastric and atomized administration of canagliflozin inhibit inflammatory cytokine storm in lipopolysaccharide-treated sepsis in mice: A potential COVID-19 treatment.

Authors:  Yaoyun Niu; Yang Chen; Pengbo Sun; Yangyang Wang; Jingyi Luo; Yipei Ding; Weidong Xie
Journal:  Int Immunopharmacol       Date:  2021-05-09       Impact factor: 5.714

3.  Special Issue "Emerging Viruses 2020: Surveillance, Prevention, Evolution and Control".

Authors:  Fabrício Souza Campos; Luciana Barros de Arruda; Flávio Guimaraes da Fonseca
Journal:  Viruses       Date:  2021-02-06       Impact factor: 5.048

4.  SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people.

Authors:  Tara M Narowski; Kristin Raphel; Lily E Adams; Jenny Huang; Nadja A Vielot; Ramesh Jadi; Aravinda M de Silva; Ralph S Baric; John E Lafleur; Lakshmanane Premkumar
Journal:  Cell Rep       Date:  2022-01-20       Impact factor: 9.995

5.  Plasma Proteome Fingerprints Reveal Distinctiveness and Clinical Outcome of SARS-CoV-2 Infection.

Authors:  Wolfgang Bauer; Marcus Weber; Eva Diehl-Wiesenecker; Noa Galtung; Monika Prpic; Rajan Somasundaram; Rudolf Tauber; Jochen M Schwenk; Patrick Micke; Kai Kappert
Journal:  Viruses       Date:  2021-12-07       Impact factor: 5.048

6.  Artificial Intelligence Predicts Severity of COVID-19 Based on Correlation of Exaggerated Monocyte Activation, Excessive Organ Damage and Hyperinflammatory Syndrome: A Prospective Clinical Study.

Authors:  Olga Krysko; Elena Kondakova; Olga Vershinina; Elena Galova; Anna Blagonravova; Ekaterina Gorshkova; Claus Bachert; Mikhail Ivanchenko; Dmitri V Krysko; Maria Vedunova
Journal:  Front Immunol       Date:  2021-08-27       Impact factor: 7.561

7.  Distinct Metabolic Profile Associated with a Fatal Outcome in COVID-19 Patients during the Early Epidemic in Italy.

Authors:  Nicola Stefano Fracchiolla; Ujjwal Neogi; Elisa Saccon; Alessandra Bandera; Mariarita Sciumè; Flora Mikaeloff; Abid A Lashari; Stefano Aliberti; Michael C Sachs; Filippo Billi; Francesco Blasi; Erin E Gabriel; Giorgio Costantino; Pasquale De Roberto; Shuba Krishnan; Andrea Gori; Flora Peyvandi; Luigia Scudeller; Ciro Canetta; Christian L Lorson; Luca Valenti; Kamal Singh; Luca Baldini
Journal:  Microbiol Spectr       Date:  2021-09-01

8.  Susceptibility and risk of SARS-COV-2 infection among middle-aged and older adults in Tarragona area, Spain.

Authors:  Eva M Satué-Gracia; Angel Vila-Córcoles; Cinta de Diego-Cabanes; Angel Vila-Rovira; Cristina Torrente-Fraga; Frederic Gómez-Bertomeu; Imma Hospital-Guardiola; Olga Ochoa-Gondar; Francisco Martín-Luján
Journal:  Med Clin (Engl Ed)       Date:  2022-04-23

9.  Susceptibility and risk of SARS-COV-2 infection among middle-aged and older adults in Tarragona area, Spain.

Authors:  Eva M Satué-Gracia; Angel Vila-Córcoles; Cinta de Diego-Cabanes; Angel Vila-Rovira; Cristina Torrente-Fraga; Frederic Gómez-Bertomeu; Imma Hospital-Guardiola; Olga Ochoa-Gondar; Francisco Martín-Luján
Journal:  Med Clin (Barc)       Date:  2021-05-07       Impact factor: 1.725

Review 10.  Root Causes of Fungal Coinfections in COVID-19 Infected Patients.

Authors:  Arman Amin; Artin Vartanian; Nicole Poladian; Alexander Voloshko; Aram Yegiazaryan; Abdul Latif Al-Kassir; Vishwanath Venketaraman
Journal:  Infect Dis Rep       Date:  2021-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.